Date Title  
Nov 05, 2018
Summary ToggleSol-Gel Technologies Announces Participation in Upcoming Investor Conference
 
Nov 01, 2018
Summary ToggleSol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic Product Candidate with Perrigo
 
Sep 25, 2018
Summary ToggleSol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III Epsolay® Program for the Treatment of Papulopustular Rosacea
 
Sep 13, 2018
Summary ToggleSol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors
 
Sep 04, 2018
Summary ToggleSol-Gel Technologies Provides Program Update for TWIN for the Treatment of Acne Vulgaris
 
Aug 15, 2018
Summary ToggleSol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo
 
Aug 08, 2018
Summary ToggleSol-Gel Technologies Reports Second Quarter 2018 Financial Results
 
Jun 18, 2018
Summary ToggleSol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea
 
May 29, 2018
Summary ToggleSol-Gel Technologies Announces Participation in Upcoming Investor Conferences
 
May 15, 2018
Summary ToggleSol-Gel Technologies Reports First Quarter 2018 Financial Results
 
Displaying 31 - 40 of 46 results